---

Intravenous ferric carboxymaltose versus iron sucrose in iron deficiency anemia of pregnancy

---

Original Article

Author Details : Aneri Parikh*, Shonali Agarwal

Volume : 9, Issue : 1, Year : 2022

Article Page : 10-14

https://doi.org/10.18231/j.ijogr.2022.003

Suggest article by email

Get Permission

---

Abstract

Introduction: Iron deficiency is the most common nutritional deficiency worldwide. Anemia, defined by the World Health Organization as hemoglobin < 11> Materials and Methods : A comparative, interventional, prospective study was carried out in 100 antenatal patients with Anemia (hemoglobin level between 5 to 9.5 gm/dl) in the department of obstetrics and gynecology, Government Medical College, Baroda, Gujarat, India from September 2017 to August 2018. The subjects were randomized in two groups. First group receiving 1000 mg of intravenous iron sucrose divided in five doses on alternate days (200 mg each) and Second group receiving 1000 mg of intravenous ferric carboxymaltose.
Results: Maximum number of patients in our study were belonged to low socioeconomic group, significantly higher number of women achieved rise of hemoglobin >2gm/dl in FCM group, which was highly significant (p value <0> Conclusions: Ferric carboxymaltose is an efficient and better alternative to Iron Sucrose in treating iron deficiency anemia of pregnancy. It has an added advantage of single dose regime with lower side effects.
 

Keywords: Iron sucrose, Ferric carboxymaltose, Iron deficiency anemia.

How to cite : Parikh A, Agarwal S, Intravenous ferric carboxymaltose versus iron sucrose in iron deficiency anemia of pregnancy. Indian J Obstet Gynecol Res 2022;9(1):10-14

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.